U.S. patent number 3,920,580 [Application Number 05/378,687] was granted by the patent office on 1975-11-18 for liquid control solution.
This patent grant is currently assigned to Miles Laboratories, Inc.. Invention is credited to Raymond L. Mast.
United States Patent |
3,920,580 |
Mast |
November 18, 1975 |
Liquid control solution
Abstract
A stable liquid control solution useful with dry reagent strips
which strips are for determining whether or not glucose is present
in blood or serum. The control solution comprising water, an
antidiffusing agent and glucose. The antidiffusing agent may be
selected from materials such as polyvinylpyrrolidone, polyvinyl
alcohol, polyethylene glycol, dextran and bovine serum albumin. The
control solution may also include adjuvants such as preservatives,
common salts, dyes, colored latex particles, etc.
Inventors: |
Mast; Raymond L. (Elkhart,
IN) |
Assignee: |
Miles Laboratories, Inc.
(Elkhart, IN)
|
Family
ID: |
23494133 |
Appl.
No.: |
05/378,687 |
Filed: |
July 12, 1973 |
Current U.S.
Class: |
436/14; 435/14;
435/803; 436/15; 436/18; 422/417 |
Current CPC
Class: |
C12Q
1/54 (20130101); Y10T 436/105831 (20150115); Y10S
435/803 (20130101); Y10T 436/104998 (20150115); Y10T
436/108331 (20150115) |
Current International
Class: |
C12Q
1/54 (20060101); C09K 003/00 (); G01N 031/00 () |
Field of
Search: |
;252/408
;23/23B,23M,253TP ;195/13.5C ;424/2,101,80,78 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
867,192 |
|
May 1961 |
|
UK |
|
880,526 |
|
Oct 1961 |
|
UK |
|
Primary Examiner: Padgett; Benjamin R.
Assistant Examiner: Gron; T. S.
Claims
What is claimed is:
1. A stable liquid control solution including a predetermined
amount of glucose for use in determining the validity of a dry
reagent strip capable of indicating amounts of glucose in blood or
blood serum which solution emulates whole blood or blood serum used
with said strip, the solution comprising water, glucose, a
preservative, and between about 3 and 35 percent by weight of an
antidiffusing agent selected from the group consisting of
polyvinylpyrrolidone, polyvinyl alcohol, polyethylene glycol,
dextran and bovine serum albumin.
2. The solution of claim 1 in which said antidiffusing agent is
polyvinylpyrrolidone.
3. The solution of claim 1 in which said antidiffusing agent is
polyethylene glycol.
4. The solution of claim 1 in which said antidiffusing agent is
dextran.
5. The solution of claim 1 in which said preservative is present in
an amount between about 0.01 and 0.3 percent by weight.
6. The solution of claim 1 which additionally includes a common
salt.
7. The solution according to claim 6 in which said common salt is
sodium chloride.
Description
BACKGROUND OF THE INVENTION
This invention relates to a stable liquid control solution for use
in establishing the validity of dry reagent strips which strips are
for determining whether or not glucose is present in blood or
serum. More specifically, this invention relates to a stable
control solution including a predetermined amount of glucose which
solution emulates whole blood or blood serum when applied to a
reagent strip for glucose.
It is recognized that reagent strips are widely used for detecting
specific materials in solutions. Such strips have become popular
because of the accuracy and convenience thereof and the rapid
production of results thereby. It is also known that data generated
by these strips are highly reproducible if the strips have been
properly prepared, stored and handled. An example of such a reagent
strip for determining glucose in blood is sold under the trademark
DEXTROSTIX by Ames Company Division, Miles Laboratories, Inc.
Recently machines have been available that read such strips. Some
of these machines are even capable of giving quantitative amounts
of the unknown material in the solution being tested. With such
accuracy, it is important that the reagent strips function
properly. Further, although these machines yield accurate
determinations with properly prepared, stored and handled strips,
they cannot readily detect faulty strips as can a human
counterpart. One such machine is the Ames Reflectance Meter
available from Ames Company Division, Miles Laboratories, Inc.
To insure the proper reactivity and to establish the validity of
such test devices, it has been desirable to have available a
control solution. Although the ideal control would be a whole blood
solution for which these test devices are primarily designed, this
material is unsuitable because of its instability when stored,
glycolysis of glucose in the whole blood, the inherent variability
of blood from one individual to another and the critical storage
conditions required for this material. Accordingly, whole blood has
not been found suitable for use as a control for this test.
It has also been suggested that a simple aqueous solution of
glucose be employed as a control solution. In practice, however,
such solutions have not produced results consistent with the amount
of glucose therein. Also, a noticeable lack of reproducibility has
been observed when such solutions are used with dry reagent
strips.
SUMMARY OF THE INVENTION
This invention is embodied in a stable liquid control solution
including a predetermined amount of glucose for use with dry
reagent glucose indicating strips. The solution comprises water, an
antidiffusing agent, and a predetermined quantity of glucose.
Accordingly, it is an object of this invention to provide a stable
control solution for confirming the validity of a dip-and-read dry
reagent strip of the type for determining an unknown glucose
concentration in a solution.
Another object of this invention is to provide a control solution
for evaluating the technique of a user of such a strip.
A further object of this invention is to provide a control solution
that is stable for an extended period of time at normal room
temperatures which solution emulates the behavior of whole blood or
serum when used with a dry reagent strip.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
It has unexpectedly been found that a control solution suitable for
use with dry reagent glucose indicating strips with a high degree
of reproducibility in test results may be formed by including in an
aqueous solution of glucose an antidiffusing agent. With the
incorporation of such an agent in this solution, results are
obtained with reagent strips which are substantially identical to
or proportional to the results observed when whole blood or serum
having similar quantities of glucose is evaluated. Although the
mechanism of action of this antidiffusing agent is not fully
understood, it is believed that it modifies the viscosity and the
osmotic pressure of the control solution so as to avoid the adverse
effects previously mentioned for an aqueous glucose solution. Such
materials are readily soluble in water and have a medium or high
molecular weight. Examples of such antidiffusing agents, which may
be used singly or in combination, include polyvinylpyrrolidone,
polyvinyl alcohol, polyethylene glycol, dextran and bovine serum
albumin. Beneficially, the control solution includes between about
3 and 35% of antidiffusing agent and preferably between about 20
and 30% thereof.
The D-glucose included in the control solution is preferably a high
grade glucose such that an accurate weight percent thereof in the
control solution may be determined. It is understood in this
application that D-glucose and dextrose are considered equivalent
materials and may be substituted one for the other without altering
the novel control solution of this invention. Although the amount
of glucose in the solution is not considered critical, within the
solubility limit of the solution, it is preferable to include
between about 1-1000 mg % (mg/100 ml solution) therein.
It has been found advantageous, although not essential, to include
in this control solution common salts such as, for example, alkali
metal salts of halogens, a phosphate or a sulfate. Preferred salts
include sodium chloride, potassium chloride, potassium phosphate
and the like. It is believed that such salts further adjust the
osmotic pressure of this control solution so that it more closely
emulates whole blood or serum. Satisfactory control solutions are
obtainable with between about 0 and 25% salt therein, and
preferably between about 1 and 4% salt is included in the
solution.
It is benefical to include in the novel control solution of this
invention a preservative so as to avoid microbial growth therein.
Such preservative may be selected from the numerous materials which
are known to have this property. Representative compositions for
this function include benzoic acid, sodium benzoate, dichlorophene,
hexachlorophene, quaternary ammonium compounds, sorbic acid,
phosphoric acid and esters of p-hydroxybenzoic acid. The
preservative may be included in an amount corresponding to accepted
levels, such as, between about 0.01 and 0.3%.
Further adjuvants may be added to the solution to obtain a
particular color or physical appearance. A red blood color may be
obtained by incorporating therewith a red, water insoluble lake
dye. Other water insoluble or water soluble dyes producing desired
colors may be included therein. Further, a blood appearance may be
enhanced by the addition of inert colored latex particles
thereto.
The novel liquid control solution of this invention and the
preparation thereof will be further described in the following
examples which set forth specific embodiments of this invention
which are only representative thereof and do not limit the scope or
use of this invention in any way.
EXAMPLE 1
A stable liquid control solution was prepared by dissolving in 88
ml. of water at a temperature of about 100.degree.C. 0.2 gm.
benzoic acid, 30 gm. of polyvinylpyrrolidone and 45 mg. of
anhydrousdextrose. Upon dissolution of these ingredients in the
warm water, water was added to bring the solution to a volume of
100 ml. This procedure was further used to prepare four more
solutions having glucose concentration of 90, 130, 175 and 250 mg.
%. Upon cooling, these solutions had a clear appearance and were
free of precipitants.
With clean eye droppers, a large drop of each solution was applied
to separate reagent areas respectively of glucose indicating
reagent strips (DEXTROSTIX). After 60 seconds, each drop was washed
from the surface of the reagent strip with water and the amount of
glucose therein determined by comparing the color of the reagent
strip with a color block calibrated therefor. it was observed that
the colors of the reagent strips indicated 45, 90, 130, 175 and 250
mgs. glucose per 100 ml. blood respectively corresponding to the
amount of glucose incorporated in each control solution.
EXAMPLE 2
The procedure of this example was substantially the same as that of
Example 1 except that the following ingredients were combined with
the dextrose and the water to form the five dextrose solutions.
______________________________________ Material Weight
______________________________________ Polyvinylpyrrolidone 13.34
gm. Bovine Serum albumin, fraction V 3.33 gm. Sodium Chloride 2.67
gm. Benzoic Acid 0.2 gm. ______________________________________
These solutions had an appearance substantially the same as the
solutions prepared in Example 1 and were observed to develop a
proper color change when applied to DEXTROSTIX.
EXAMPLE 3
The procedure of this Example was substantially the same as that of
Example 1 except that the following ingredients were combined with
the dextrose and the water to form the five dextrose solutions.
______________________________________ Material Weight
______________________________________ Benzoic Acid 0.2 gm.
Polyvinylpyrrolidone 30. gm. FD&C Red No. 2, Aluminum Lake
0.175 gm. FD&C Red No. 40, Aluminum Lake 0.175 gm.
______________________________________
The solutions of this Example had a color appearance substantially
the same as whole blood. When applied to DEXTROSTIX according to
the procedure of Example 1, correct color changes were
observed.
EXAMPLE 4
The procedure of this example was substantially the same as that of
Example 1 except that the following ingredients were combined with
the dextrose and the water to form the five dextrose solutions.
______________________________________ Material Weight
______________________________________ Benzoic Acid 0.2 gm.
Polyvinylpyrrolidone 20 gm. FD&C Red No. 2, Aluminum Lake 0.175
gm. FD&C Red No. 40, Aluminum Lake 0.175 gm. Sodium Chloride
2.25 gm. ______________________________________
These solutions had substantially the same appearance and
reactivity as the solutions of Example 3.
EXAMPLE 5
The procedure of this example was substantially the same as that of
Example 1 except that the following ingredients were combined with
the dextrose and the water to form the five dextrose solutions.
______________________________________ Material Weight
______________________________________ Benzoic Acid 0.2 gm.
Polyethylene glycol 25 gm. (4000-9000 mol. wt.)
______________________________________
These solutions had substantially the same appearance and
reactivity as the solutions of Example 1.
EXAMPLE 6
The procedure of this example was substantially the same as that of
Example 1 except that the following ingredients were combined with
the dextrose and the water to form the five dextrose solutions.
______________________________________ Material Weight
______________________________________ Benzoic Acid 0.2 gm. Dextran
25 gm. ______________________________________
These solutions had substantially the same appearance and
reactivity as the solutions of Example 1.
Based on accelerated stability evaluations, it has been concluded
that the unique liquid control solution of this invention is stable
for at least 5 years at about room temperature if properly stored
in a closed container. With such stability and reproducible results
with reagent strips, a stable liquid control solution is provided
which meets the criteria desired for such a control solution but
which were previously unobtainable.
* * * * *